Bristol-Myers Squibb
BMY
#174
Rank
HK$935.48 B
Marketcap
HK$458.18
Share price
1.44%
Change (1 day)
8.26%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): HK$26.97

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is HK$27.10. an increase over its 2024 EPS that were of -HK$34.62.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025HK$27.02-178.05%
2024-HK$34.62-213.92%
2023HK$30.3930.2%
2022HK$23.34-6.04%
2021HK$24.84-179.29%
2020-HK$31.33-281%
2019HK$17.31-27.06%
2018HK$23.73
2016HK$20.91175.26%
2015HK$7.60-19.83%
2014HK$9.48-22.44%
2013HK$12.2234.48%
2012HK$9.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.24 221.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$56.39 108.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.65-60.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$18.73-30.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$180.33 565.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$112.23 314.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$16.17-40.31%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$69.16 155.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.26 111.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$46.44 71.39%๐Ÿ‡ฌ๐Ÿ‡ง UK